Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T08:28:09.173Z Has data issue: false hasContentIssue false

Mental health of people living with dementia in care homes during COVID-19 pandemic

Published online by Cambridge University Press:  03 June 2020

Latha Velayudhan*
Affiliation:
Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, LondonSE5 8AF, UK
Dag Aarsland
Affiliation:
Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, LondonSE5 8AF, UK Stavanger University Hospital, Centre for Age-Related Research, 4000Stavanger, Norway
Clive Ballard
Affiliation:
The University of Exeter Medical School, St Luke’s Campus, Magdalen Road, ExeterEX1 2LU, UK
*
Correspondence should be addressed to: Latha Velayudhan, Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, LondonSE5 8AF, UK. Email: latha.velayudhan@kcl.ac.uk.
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© International Psychogeriatric Association 2020

The COVID-19 pandemic has been causing significant challenges across all areas of society. By virtue of prevalent frailty and multimorbidity, care home residents remain vulnerable to COVID-19 until effective vaccines are developed (Gordon et al., Reference Gordon2020). The current health crisis and the enforced isolation can have huge impact to the mental health of this vulnerable individuals, the majority of whom have dementia and are also at significantly increased risk of severe COVID-19.

At least two-thirds of care home residents and probably more than 80% have dementia (Prince, Reference Prince2014). Ninety-eight percent of people living with dementia (PlwD) experience neuropsychiatric symptoms over the course of their disease (Vik-Mo et al., Reference Vik-Mo, Giil, Borda, Ballard and Aarsland2020). With the ongoing COVID-19 viral pandemic, older people, especially PlwD and care-dependent, may become more anxious, agitated, lonely, and depressed during the outbreak or while in isolation, with huge impact on quality of life, care burden, and use of resources. The increased morbidity and mortality in elderly and care home residents will further affect mental well-being with fear of illness and death in the residents. PlwD will be unable to understand the information on social distancing or to practice it. They will have confusion and distress around relatives not visiting. Limited social interaction and activities with fellow residents, families, and staff due to social distancing can also lead to boredom, inactivity, and sedentary behaviour in residents, further leading to loneliness. Both loneliness and social isolation have been linked to poor mental health (e.g., depression, hopelessness, and cognitive impairment), as well as worse physical health (e.g., worse motor function, cardiovascular health, disrupted sleep, frailty), and higher mortality (Leigh-Hunt et al., Reference Leigh-Hunt2017; Santini et al., Reference Santini2020). Imposed isolation can also result in sedentary behaviour which is critical in the prevention of physical, psychological, and social health problems (Maher and Conroy, Reference Maher and Conroy2017). It must also be frightening to PlwD when people approach them using personal protective equipment for interpersonal care (care home staff) or by health professionals. With current pandemic, there is a risk for increased use of antipsychotics, hypnotics, and other sedatives in residents with behaviour problems (such as wandering, agitation, or aggression) to ensure compliance with social distancing and to cope with staff shortage. Substantial work has been going on to optimise the use of medications especially antipsychotics, as they have harmful side effects in elderly and especially those with PlwD, and its increased use can double death rates and triple the stroke rates, with the potential to undo more than 10 years of significant progress in the rates of use (Kales et al., Reference Kales, Lyketsos, Miller and Ballard2019; Romeo et al., Reference Romeo, Zala, Knapp, Orrell, Fossey and Ballard2019) and we have evidence from Randomised Controlled Trials and big data studies that the reduction in antipsychotics has led to 30% reductions in both mortality and strokes in this vulnerable population (Sultana et al., Reference Sultana2019). There is a serious concern that without proactive training and support in care homes, that the current pandemic will reverse all of this progress and also lead to significant increases in morbidity and mortality that compound the effects of COVID-19.

We have demonstrated that the Well-being and Health for people with Dementia (WHELD) training programme to promote person-centred care and person-centred activities significantly improve quality of life for PlwD (Kales et al., Reference Kales, Lyketsos, Miller and Ballard2019), as well as reducing neuropsychiatric symptoms and reduce the use of antipsychotic drugs, and recently demonstrated that an eLearning version of the programme also significantly improves the well-being of residents (McDermid et al., Reference McDermid, Fossey, Da Silva and Ballard2018). In the light of the pandemic, there is urgent need for innovative training interventions and non-pharmacological approaches for neuropsychiatric symptoms in PlwD that are person-centred, easy to deliver, and culturally competent to improve health outcomes within care home settings and avoid unnecessary hospital admissions during these tough periods of social distancing and isolation.

Conflict of interest

None.

Description of authors’ roles

LV drafted the letter. CB and DA critically revised the letter. All authors read and approved the final manuscript.

References

Gordon, A. L. et al. (2020). Commentary: COVID in care homes-challenges and dilemmas in healthcare delivery. Age and Ageing. doi:10.1093/ageing/afaa113 CrossRefGoogle Scholar
Kales, H. C., Lyketsos, C. G., Miller, E. M. and Ballard, C. (2019). Management of behavioral and psychological symptoms in people with Alzheimer’s disease: an international Delphi consensus. International Psychogeriatrics, 31, 8390.10.1017/S1041610218000534CrossRefGoogle Scholar
Leigh-Hunt, N. et al. (2017). An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health, 152, 157171.10.1016/j.puhe.2017.07.035CrossRefGoogle ScholarPubMed
Maher, J. P. and Conroy, D. E. (2017). Daily life satisfaction in older adults as a function of (in)activity. The Journals of Gerontology Series B Psychological Sciences and Social Sciences, 72, 593602.Google Scholar
McDermid, J., Fossey, J., Da Silva, M. and Ballard, C. (2018). Randomized controlled trial evaluating the impact of an e-learning intervention based on improving wellbeing and health for people with dementia (WHELD) programme (abstract). Alzheimer’s & Dementia, 14, 1406.10.1016/j.jalz.2018.06.2926CrossRefGoogle Scholar
Prince, M. et al. (2014). Dementia UK: Update, 2nd ed. London: Alzheimer’s Society.Google Scholar
Romeo, R., Zala, D., Knapp, M., Orrell, M., Fossey, J. and Ballard, C. (2019). Improving the quality of life of care home residents with dementia: cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia. Alzheimer’s & Dementia, 15, 282291.10.1016/j.jalz.2018.08.010CrossRefGoogle ScholarPubMed
Santini, Z. I. et al. (2020). Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis. Lancet Public Health, 5, e62e70.10.1016/S2468-2667(19)30230-0CrossRefGoogle ScholarPubMed
Sultana, J. et al. (2019). Measuring the effectiveness of safety warnings on the risk of stroke in older antipsychotic users: a nationwide cohort study in two large electronic medical records databases in the United Kingdom and Italy. Drug Safety, 42, 14711485.10.1007/s40264-019-00860-zCrossRefGoogle ScholarPubMed
Vik-Mo, A. O., Giil, L. M., Borda, M. G., Ballard, C. and Aarsland, D. (2020). The individual course of neuropsychiatric symptoms in people with Alzheimer’s and Lewy body dementia: 12-year longitudinal cohort study. British Journal of Psychiatry, 216, 4348.CrossRefGoogle ScholarPubMed